Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

被引：4

作者：

Criscuolo, Marianna ^{[1
]}

Chiusolo, Patrizia ^{[1
]}

Giammarco, Sabrina ^{[1
]}

Giachelia, Manuela ^{[1
]}

Fianchi, Luana ^{[1
]}

Fabiani, Emiliano ^{[1
]}

Falconi, Giulia ^{[1
]}

Hohaus, Stefan ^{[1
]}

Sica, Simona ^{[1
]}

Leone, Giuseppe ^{[1
]}

Voso, Maria Teresa ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Ist Ematol, I-00168 Rome, Italy

来源：

LEUKEMIA & LYMPHOMA | 2014年 / 55卷 / 12期

关键词：

DNA METHYLATION; COMMON MUTATION; PHASE-III; LEUKEMIA; RISK; DISEASE; AZACITIDINE; HAPLOTYPE; CANCER; GENE;

D O I：

10.3109/10428194.2014.903475

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2942 / 2944

页数：3

共 15 条

[1] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].

Cheson, Bruce D. ;

Greenberg, Peter L. ;

Bennett, John M. ;

Lowenberg, Bob ;

Wijermans, Pierre W. ;

Nimer, Stephen D. ;

Pinto, Antonio ;

Beran, Miloslav ;

de Witte, Theo M. ;

Stone, Richard M. ;

Mittelman, Moshe ;

Sanz, Guillermo F. ;

Gore, Steven D. ;

Schiffer, Charles A. ;

Kantarjian, Hagop .

BLOOD, 2006, 108 (02) :419-425

[2] Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia [J].

Christiansen, DH ;

Andersen, MK ;

Pedersen-Bjergaard, J .

LEUKEMIA, 2003, 17 (09) :1813-1819

[3] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Finelli, Carlo ;

Giagounidis, Aristoteles ;

Schoch, Robert ;

Gattermann, Norbert ;

Sanz, Guillermo ;

List, Alan ;

Gore, Steven D. ;

Seymour, John F. ;

Bennett, John M. ;

Byrd, John ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

LANCET ONCOLOGY, 2009, 10 (03) :223-232

[4] Outcome of therapy-related myeloid neoplasms treated with azacitidine [J].

Fianchi, Luana ;

Criscuolo, Marianna ;

Lunghi, Monia ;

Gaidano, Gianluca ;

Breccia, Massimo ;

Levis, Alessandro ;

Finelli, Carlo ;

Santini, Valeria ;

Musto, Pellegrino ;

Oliva, Esther N. ;

Leoni, Pietro ;

Spiriti, Antonietta Aloe ;

D'Alo, Francesco ;

Hohaus, Stefan ;

Pagano, Livio ;

Leone, Giuseppe ;

Voso, Maria Teresa .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5

[5] MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation [J].

Figueroa, Maria E. ;

Skrabanek, Lucy ;

Li, Yushan ;

Jiemjit, Anchalee ;

Fandy, Tamer E. ;

Paietta, Elisabeth ;

Fernandez, Hugo ;

Tallman, Martin S. ;

Greally, John M. ;

Carraway, Hetty ;

Licht, Jonathan D. ;

Gore, Steven D. ;

Melnick, Ari .

BLOOD, 2009, 114 (16) :3448-3458

[6] A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status [J].

Friso, S ;

Choi, SW ;

Girelli, D ;

Mason, JB ;

Dolnikowski, GG ;

Bagley, PJ ;

Olivieri, O ;

Jacques, PF ;

Rosenberg, IH ;

Corrocher, R ;

Selhub, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5606-5611

[7] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].

FROSST, P ;

BLOM, HJ ;

MILOS, R ;

GOYETTE, P ;

SHEPPARD, CA ;

MATTHEWS, RG ;

BOERS, GJH ;

DENHEIJER, M ;

KLUIJTMANS, LAJ ;

VANDENHEUVEL, LP ;

ROZEN, R .

NATURE GENETICS, 1995, 10 (01) :111-113

[8] Role of MTHFR (677,1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies [J].

Guillem, V. M. ;

Collado, M. ;

Terol, M. J. ;

Calasanz, M. J. ;

Esteve, J. ;

Gonzalez, M. ;

Sanzo, C. ;

Nomdedeu, J. ;

Bolufer, P. ;

Lluch, A. ;

Tormo, M. .

LEUKEMIA, 2007, 21 (07) :1413-1422

[9] The myelodysplastic syndrome as a prototypical epigenetic disease [J].

Issa, Jean-Pierre J. .

BLOOD, 2013, 121 (19) :3811-3817

[10] Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic Syndromes [J].

Khan, Hina ;

Vale, Cristina ;

Bhagat, Tushar ;

Verma, Amit .

SEMINARS IN HEMATOLOGY, 2013, 50 (01) :16-37

← 1 2 →